---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-036131"
form_type: "8-K"
ticker: "CBUS"
cik: "0001705843"
company_name: "Cibus, Inc."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T11:03:29.933923+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cibus reports Q2 net loss of $28.5M; cash $30M; sees runway into Q4 2024

## Summary
- Net loss of $28.5M ($1.14 loss per share) vs $20.5M loss in year-ago period (not comparable due to merger).
- Cash and cash equivalents $30M; expects to fund operations into Q4 2024 without additional financing.
- R&D expense $13.0M (+55% YoY); SG&A $9.3M (-16% YoY).
- Commercial progress: signed fourth rice HT trait customer FEDEARROZ; Wheat platform operational; Sclerotinia and NUE edits achieved in canola.
- Regulatory advances in Canada, UK, EU; IP expanded across 10 trait families.

## SEC filing metadata
- accession: 0001628280-24-036131
- form_type: 8-K
- ticker: CBUS
- cik: 0001705843
- company_name: Cibus, Inc.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1705843/000162828024036131/0001628280-24-036131-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1705843/000162828024036131/cbus-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-036131
- JSON: https://secwatch.observer/filing/0001628280-24-036131.json
- Plain text: https://secwatch.observer/filing/0001628280-24-036131.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.